Crossmark

2-substituted 4-aminoquinazoline derivatives as potential dual inhibitors of EGFR and HER2: an in silico and in vitro study

Published Online: 2022-03-23

Published Print: 2022-05

Authors

Sangande, Frangky

Julianti, Elin

Tjahjono, Daryono Hadi https://orcid.org/0000-0002-9675-0134
Funding

Funding for this research was provided by:

bandung institute of technology (014/SK/I1.C03/KP/2020)
License Information

Text and Data Mining valid from 2022-03-23

Version of Record valid from 2022-03-23
More Information

Article History

Received: 17 June 2021

Accepted: 6 March 2022

First Online: 23 March 2022

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current